纳米工程化GATA3+巨噬细胞移植可重建肌肉干细胞生态位 促进骨骼肌再生
Nanoengineered GATA3+ Macrophages Transplantation Reconstitutes the Muscle Stem Cells Niche for Skeletal Muscle Regeneration
Peiwen Zhang, Yahong Xu, Yimeng Zhang, Jing Yang, Shuyun Liu, Yujia Yuan, Younan Chen, Chunhong Li, Yanrong Lu, Hui Wang, Jingping Liu
Journal:International Journal of Nanomedicine
IF:8.7
DOI:10.2147/IJN.S623194
PMID:42733887
Published:2026-09-09
research field:分子生物学细胞生物学再生医学骨代谢钙信号传导
Abstract
Introduction Severe skeletal muscle injury is a serious disease worldwide, but current clinical treatments are unsatisfactory because of the limited ability of these treatments to repair muscle; thus, novel therapies that can efficiently promote muscle regeneration are desirable.Methods Nanoengineered GATA3+ macrophages (nanoGMφs) were constructed by loading IL-33-induced GATA3+ Mφs with PLGA nanoparticles encapsulating the efferocytosis agonist (aEffero) VU534 (a small molecule that enhances efferocytosis by activating the N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) pathway), and their ability to reestablish the pro-regenerative muscle stem cell (MuSC) niche was evaluated both in vitro and in vivo.Results Our data revealed that dysregulation of GATA3⁺ macrophage subsets and the accumulation of harmful dead cells compromised the MuSC niche after severe skeletal muscle injury. In vitro, GATA3+ Mφs promoted MuSC activation (eg, proliferation, migration, and differentiation) via metabolic regulation. The average diameter of the VU534-loaded PLGA nanoparticles was ~200 nm, with an encapsulation efficiency of ~94.7% and a drug-loading capacity of ~7.3%. Moreover, nanoGMφs secrete EVs that regulate the immune microenvironment locally. In vivo, adoptive nanoGMφ transplantation effectively promoted MuSC activation and the clearance of dead cells and debris, thereby enhancing MuSC niche restoration and skeletal muscle regeneration in two models of acute chemically induced muscle injury. On day 7, the proportions of centrally nucleated myofibers in the nanoGMφ-treated muscles were 1.52 and 1.38 times greater than those in the untreated controls in the CTX and BaCl2 models, respectively. On day 21, compared with the control treatment, the nanoGMφ treatment increased the mean myofiber CSA by 29.38% and 17.42% in the CTX and BaCl2 models, respectively.Conclusion This study highlights that the tailored design of engineered immune cell therapy is a promising strate
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


